- CA$119.24m
- CA$210.08m
- CA$370.75m
- 48
- 89
- 62
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 44.63 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.46 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 6.38 | ||
| Price to Sales | 0.32 | ||
| EV to EBITDA | 9 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.99% | ||
| Return on Equity | -7.4% | ||
| Operating Margin | 0.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 124.63 | 162.2 | 262.63 | 381.73 | 370.75 | 369.18 | 386.41 | 25.54% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 1st, 2017
- Public Since
- September 4th, 2002
- No. of Employees
- 1,444
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
Toronto Stock Exchange- Shares in Issue
- 59,921,923
- Address
- 320 Bay St. Suite 1200, TORONTO, M5H 4A6
- Web
- https://www.carerx.ca/
- Phone
- +1 6473614499
- Auditors
- Ernst & Young LLP
Upcoming Events for CRRX
Q1 2024 CareRx Corp Earnings Release
CareRx Corp Annual Shareholders Meeting
Q2 2024 CareRx Corp Earnings Release
Similar to CRRX
Colabor
Toronto Stock Exchange
Empire
Toronto Stock Exchange
George Weston
Toronto Stock Exchange
Loblaw Companies
Toronto Stock Exchange
Metro
Toronto Stock Exchange
FAQ
What is the CareRx share price?
As of Today at 19:04 UTC, shares in CareRx are trading at CA$1.99. This share price information is delayed by 15 minutes.
How has the CareRx share price performed this year?
Shares in CareRx last closed at CA$1.99 and the price had moved by -17.43% over the past 365 days. In terms of relative price strength the CareRx share price has underperformed the Toronto Stock Exchange 300 Composite Index by -22.4% over the past year.
What are the analyst and broker recommendations for CareRx?
The overall consensus recommendation for CareRx is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the CareRx dividend yield?
CareRx does not currently pay a dividend.
Does CareRx pay a dividend?
CareRx does not currently pay a dividend.
When does CareRx next pay dividends?
CareRx does not currently pay a dividend.
How do I buy CareRx shares?
To buy shares in CareRx you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CareRx?
As of the previous close price of CA$1.99, shares in CareRx had a market capitalisation of CA$119.24m.
Where are CareRx shares listed?
Here are the trading details for CareRx:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: CRRX
What kind of share is CareRx?
Based on an overall assessment of its quality, value and momentum CareRx is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CareRx share price forecast for 2024?
The analyst consensus target price for shares in CareRx is CA$3.93. That is 97.49% above the last closing price of CA$1.99.
Analysts covering CareRx currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.00 for the next financial year.
What is the trend in the CareRx share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CareRx. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -1.5%.
As of the last closing price of CA$1.99, shares in CareRx were trading +11.21% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CareRx PE Ratio?
The CareRx PE ratio based on its reported earnings over the past 12 months is 44.63. The shares last closed at CA$1.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CareRx?
We do not have data on CareRx's directors